The reduced pathogenicity of the omicron BA. 1 sub-lineage compared to earlier variants is
well described, although whether such attenuation is retained for later variants like BA. 5 …

Background Studies have established the short-term efficacy of nirmatrelvir–ritonavir in
managing COVID-19, yet its effect on post-COVID-19 condition, especially in patients …

OBJECTIVE: COVID-19 patients experience, in 10-20% of the cases, a prolonged long-
COVID syndrome, defined as the persistence of symptoms for at least two months after the …

Introduction Viral persistence is one of the main hypotheses explaining the presence of post-
COVID symptoms. This systematic review investigated the presence of SARS-CoV-2 RNA in …

BACKGROUND: Persistent symptoms among some persons who develop COVID-19 has
led to the hypothesis that SARS-CoV-2 may, in some form or location, persist for long …

As COVID-19 continues, an increasing number of patients develop long COVID symptoms
varying in severity that last for weeks, months, or longer. Symptoms commonly include …

The mechanisms of postacute medical conditions and unexplained symptoms after SARS-
CoV-2 infection [Long Covid (LC)] are incompletely understood. There is growing evidence …

The study aimed to assess the efficacy of transcranial direct current stimulation (tDCS) in the
treatment of neuropsychiatric (NP) symptoms of the post-acute sequelae of SARS-CoV-2 …

Throughout the SARS-CoV-2 pandemic, several variants of concern (VOCs) have been
identified, many of which share recurrent mutations in the spike glycoprotein's receptor …

The SARS-CoV-2 pandemic created a multitude of medical crossroads requiring real time
adaptations of best practice covering preventative and interventional aspects of care. Among …